Search Tag: Masimo SpHb®

ICU Management

Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb®

2018 05 Jun

Masimo  has announced  the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting iatrogenic hemodilution during incremental fluid administration of patients undergoing major surgery. 1... Read more

ICU Management

Study Investigates the Utility of Masimo SpHb® in Post-operative Red RBC Transfusion Best Practices

2018 23 Apr

Masimo announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion... Read more

ICU Management

New Study Investigates the Performance of Masimo SpHb®

2018 12 Mar

Masimo announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin (SpHb®), referenced to an invasive laboratory hemoglobin (Lab-Hb) measurement, during acute bleeding and after fluid resuscitation. In the study,... Read more

ICU Management

New Study Evaluates the Performance of Masimo SpHb® in Monitoring Pediatric Trauma Patients

2018 22 Feb

Masimo announced today the findings of a recently published study in which researchers at Michigan State University evaluated the performance of noninvasive hemodynamic monitoring (NIHM) using Masimo noninvasive and continuous hemoglobin (SpHb®), as compared to invasive laboratory hemoglobin (LabHb) monitoring, in clinically stable pediatric trauma... Read more

ICU Management

Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels

2017 10 Aug

  Masimo  (NASDAQ: MASI) has announced the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous hemoglobin measurement, in trauma patients with low hemoglobin levels. 1 In the prospective, observational study, Dr. Gamal and colleagues sought to... Read more

ICU Management

New Study Evaluates the Utility of Masimo SpHb® Monitoring During Liver Transplantation

2017 19 Mar

Masimo  (NASDAQ: MASI) has announced the publication of a recent study conducted on adult patients undergoing liver transplantation (LT), in which researchers assessed the accuracy and trending ability of noninvasive Masimo SpHb® (total hemoglobin) measurement, as compared to conventional laboratory hemoglobin (HbL) measurements. The researchers found... Read more